Quick Picks - Sarepta Therapeutics (NASDAQ:SRPT) is up nearly 13% in pre-market trading on a story highlighting a Duchenne Muscular Dystrophy (DMD) patient’s progress on the company’s development-stage … Continue Reading
Read NowQuick Picks - Warner Chilcott (NASDAQ:WCRX) opened down 23% from Tuesday’s closing price of $16.90 after the company announced that the ex-dividend date for its $4 special dividend … Continue Reading
Read NowQuick Picks - ArQule Inc. (NASDAQ:ARQL), co-developer of the tivantinib cancer treatment, received word from its Japanese partner Kyowa Hakko Kirin Co., that Kyowa has suspended patient enrollment … Continue Reading
Read NowQuick Picks - Cyberonics Inc. (NASDAQ:CYBX) today released Fiscal 1Q 2013 results that beat analyst expectations, sending shares up 10% in early trading, only to decline slightly into … Continue Reading
Read NowLong Ideas - Amarin Pharmaceuticals (NASDAQ:AMRN) could trade higher as investors digest this morning’s news that Roche’s (OTC:RHHBY) former Head of Global Pharmaceuticals has joined AstraZeneca (NYSE:AZN) as … Continue Reading
Read NowLong Ideas - Catalyst Pharmaceutical Partners (NASDAQ:CPRX) announced that in a direct public offering of 4 million shares of common stock and 1.2MM warrants, it will be raising … Continue Reading
Read NowQuick Picks - Genzyme, a subsidiary of Sanofi (NYSE:SNY), announced this morning that the FDA has returned the company’s supplemental Biologics License Application (sBLA) for Lemtrada on grounds … Continue Reading
Read Now